Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Beclobrate (Sgd 24774), a fibric acid derivative, exhibits potent lipid-lowering efficacy in rodent models [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 722.00 | |
10 mg | In stock | $ 987.00 | |
25 mg | In stock | $ 1,520.00 | |
50 mg | In stock | $ 1,980.00 | |
100 mg | In stock | $ 2,500.00 |
Description | Beclobrate (Sgd 24774), a fibric acid derivative, exhibits potent lipid-lowering efficacy in rodent models [1]. |
In vivo | In rats fed a standard diet, Beclobrate administration results in a 22-33.4% decrease in total plasma cholesterol levels (10-50 mg/kg), with the majority of reduction observed in high-density lipoproteins (HDL). Furthermore, Beclobrate significantly enhances the activity of high-affinity beta-VLDL receptors in isolated liver membranes [1]. |
Molecular Weight | 346.85 |
Formula | C20H23ClO3 |
CAS No. | 55937-99-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Beclobrate 55937-99-0 inhibitor inhibit